Diamine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diamine

Property Description
Active ingredient Diphenhydramine hydrochloride
Form Tablets, capsules, oral solutions, injectable solution, topical preparations
Pharmacological class First-generation H1 receptor antagonist
General purpose Relief of allergic symptoms, Sedative/Sleep aid
Origin Synthetic (Ethanolamine derivative)

Diamine is a synthetic medicinal preparation based on the active substance Diphenhydramine hydrochloride. It is primarily categorized as a first-generation antihistamine, a compound designed to counteract the effects of histamine in the body. This substance is administered via multiple routes of administration, including oral, injectable, and topical forms, establishing its versatility. Diamine is commonly positioned for patients seeking both allergy relief and a pronounced sedative effect.


Composition and Pharmacological Class

Diamine is a single-ingredient product whose active constituent is Diphenhydramine hydrochloride, a chemically synthesized ethanolamine derivative. The drug is classified as a first-generation H1 receptor antagonist, which acts by blocking the effect of histamine, the body's natural mediator of allergic responses. This action interrupts the signal cascade that triggers symptoms like itching and sneezing.

The designation first-generation is important as it signifies the drug's key characteristic: the ability to cross the blood-brain barrier and interact with the Central Nervous System (CNS). This pronounced central action is clinically recognized as the mechanism responsible for its sedative effects. The substance is used broadly due to its efficacy as both an antihistamine and a sleep aid, a utility confirmed by the central nervous system effects inherent to its chemical structure.


General Purpose and Available Forms

The general purpose of Diamine is defined by its ability to neutralize histamine-driven symptoms and induce drowsiness. Consequently, its primary benefits include the provision of general relief for allergic symptoms and utility as a short-term sedative or sleep aid. A typical neutral use scenario involves managing acute, disruptive symptoms of a seasonal allergy flare-up that also prevents adequate rest. The medicine is found in several common dosage forms, including tablets, capsules, oral solutions (syrups), and sterile injectable solutions, alongside external topical preparations like creams. This variety in available forms allows for different types of general application, whether systemic or localized.

Regulatory References

  1. MedlinePlus Drug Information

What side effects are possible with Diamine?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse effects and safety characteristics of Diamine (Diphenhydramine hydrochloride), based strictly on government regulatory sources.


Adverse Reactions by Frequency

Side effects are categorized based on their incidence as documented in regulatory labeling.

Classification Key Adverse Reactions
Common Drowsiness, Sedation, Dizziness, Disturbed coordination, Dry mouth/throat, Nausea, Vomiting, Epigastric distress.
Uncommon/Rare Excitation (paradoxical), Nervousness, Insomnia, Palpitations, Tachycardia, Blurred vision, Urinary difficulty or retention, Headache.
Frequency Not Known Blood Dyscrasias (e.g., Agranulocytosis, Hemolytic anemia), Convulsions, Photosensitivity.

Safety Restrictions and Serious Risks

Regulatory warnings define specific populations at heightened risk and conditions where the drug is contraindicated.

  • Serious Reactions: Documented risks include Convulsions, severe Hypersensitivity Reactions (e.g., anaphylaxis), Blood Dyscrasias, and Hypotension.
  • Contraindications: The drug should not be used in cases of Narrow-Angle Glaucoma, Symptomatic Prostatic Hypertrophy, Acute Asthma Attacks, or known sensitivity to the active ingredient.
  • Population Warnings: Older adults are more susceptible to sedation, dizziness, and confusion. Pediatric patients have an increased risk of paradoxical excitation.
  • Interaction Note: Concomitant use with alcohol or other CNS depressants can lead to an enhanced and potentially dangerous sedative effect.

This official safety profile is structured to emphasize the high frequency of CNS and anticholinergic effects, while clearly defining absolute restrictions and serious, though less frequent, systemic risks.

Overdose and Emergency Response

The official regulatory profile for Diamine (Diphenhydramine hydrochloride) overdose is defined by its potential for severe central nervous system and cardiovascular toxicity. Documented manifestations range from anticholinergic signs, such as dry mouth and dilated pupils, to CNS effects including confusion, hallucinations, tremor, and profound drowsiness. Overdose may also present with life-threatening complications, including seizures, coma, and severe cardiac arrhythmias like QTc prolongation and QRS widening, which can lead to cardiac arrest.

The regulatory mandate is clear: Seek immediate medical attention or contact Poison Control when overdose is suspected. Urgent medical care is required if specific danger signs are observed, such as being unable to be awakened, experiencing convulsions, or suffering respiratory collapse.

Treatment is classified as symptomatic and supportive. No specific antidote is currently known to reverse the effects of toxicity. Supportive procedures may involve continuous monitoring of vital signs and the use of interventions such as activated charcoal or specific medications for cardiac effects. Population-specific considerations note that pediatric patients are particularly susceptible to CNS stimulation and an increased risk of convulsions in overdose, while the elderly are more prone to hypotension.

Therapeutic Uses of Diamine

Diamine is widely used for symptomatic relief across several key therapeutic areas. The medication is commonly used to help manage symptoms that interfere with daily functioning and may be part of symptomatic management for conditions associated with acute or episodic changes.

It is commonly used to help manage pronounced symptoms such as sneezing, noticeable runny nose, and significant generalized itching related to allergic rhinitis and uncomplicated hives. When used for sleep support, the drug contributes to symptomatic relief that helps patients cope more steadily with temporary insomnia. Furthermore, the medication may be applied in clinical settings that involve motion sensitivity and is commonly used to help manage symptoms like nausea and vertigo during travel.

Quick Fact: Symptomatic support for Itching, Sneezing, and Nausea

Regulatory References

  1. NIH DailyMed for Diphenhydramine Hydrochloride Capsules

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Diamine — Official Regulatory Information

Official regulatory documents strictly define the patient populations eligible or prohibited from using Diamine (Diphenhydramine).


Contraindicated Populations

Category Prohibited Population (MUST NOT USE)
Age Neonates or Premature Infants
Physiological Status Nursing Mothers (Breastfeeding)
Sensitivity Patients with known hypersensitivity to the drug or related antihistamines

Age- and Condition-Specific Restrictions

Use is not recommended or requires considerable caution in the following groups:

  • Older Adults (60+ years): Due to increased risk of sedation, dizziness, and hypotension.
  • Children under 6 years of age: Over-the-counter use is generally restricted or not recommended.
  • Comorbidities: Patients with narrow-angle glaucoma, symptomatic prostatic hypertrophy, bladder-neck obstruction, stenosing peptic ulcer, or pyloroduodenal obstruction.
  • Pregnancy: Use is generally not recommended unless clearly needed, as adequate controlled studies are insufficient.
  • MAOI Use: Contraindicated during therapy with, or within two weeks of stopping, a Monoamine Oxidase Inhibitor.

What should I know about interactions with other medicines?

Diamine Interactions with other medicines and products

While Diamine is not the common name for a single approved medicine, the term is centrally associated with the enzyme Diamine Oxidase (DAO). DAO is an enzyme that breaks down histamine in the digestive tract. Therefore, interactions are clinically significant when other substances interfere with this enzyme’s activity, potentially leading to an accumulation of histamine from food and drink.


Interacting Medicinal Products and Categories

The most significant interactions involve medicines that can inhibit DAO activity or release stored histamine in the body, which can compound histamine-related symptoms. Product categories documented to interfere with endogenous DAO activity include:

  • Monoamine Oxidase Inhibitors (MAOIs): Certain MAOIs, which are used to treat depression, can affect the function of diamine-metabolizing enzymes.
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Specific agents in this class, such as aspirin and ibuprofen, have been shown to inhibit DAO function.
  • Antihypertensive Drugs: Certain medications used to manage high blood pressure, such as verapamil, are known to interfere with DAO.
  • Mucolytics and Expectorants: Drugs used to clear mucus, such as acetylcysteine, have been identified as potential DAO inhibitors.

Interaction Mechanism and Restrictions

Mechanistic basis of interactions: The core mechanism is the inhibition of the Diamine Oxidase enzyme, reducing the body’s natural capacity to degrade histamine derived from ingested foods. This is a pharmacodynamic interaction that does not involve standard cytochrome P450 enzyme pathways. Concurrently using these inhibitors with the enzyme-containing supplement itself may reduce the supplement’s apparent efficacy or worsen baseline histamine symptoms. No specific timing-based interaction rules are officially documented, but administration with meals is typically intended to counter histamine intake. Due to the lack of official governmental labeling for a singular Diamine drug, these interactions are generally cited under the context of histamine intolerance and enzyme supplementation.

Mechanism of Action

Diamine: Mechanism of Action

Diamine Oxidase (DAO) is a key metabolic enzyme that governs the catabolism of histamine and other polyamines. DAO acts as a copper-containing enzyme, catalyzing the oxidative deamination of its primary substrate, histamine.

This interaction initiates a molecular cascade that results in the conversion of histamine, a bioactive amine, into inactive metabolites, specifically imidazole acetaldehyde, hydrogen peroxide, and ammonia. The enzyme's catalytic function thus provides a molecular pathway for histamine inactivation.

DAO is highly expressed in tissues that serve as physiological barriers, such as the intestinal mucosa and the placenta. In these locations, the enzyme is secreted locally to influence the concentration gradient of extracellular histamine originating from diet or localized release events. The degradation of circulating and locally present histamine effectively modulates signaling sequences reliant on this mediator, which subsequently affects the overall physiological response profile in systems where histamine is an influential transmitter, including the digestive and immune systems.

Dosage and Administration Information

Official Administration Guidelines

Diamine (Diphenhydramine hydrochloride) is administered via multiple routes, including oral (tablets, capsules, solutions), parenteral (Intravenous and Intramuscular injection), and topical preparations. The method of use is structured by specific instructions concerning dose, frequency, and administration context.


Dosing, Frequency, and Context

Parameter Official Guideline
Standard Adult Dose Typically 25 mg to 50 mg per dose, up to a maximum of 300 mg to 400 mg over 24 hours. Oral dosing is repeated every 4 to 6 hours as needed, or once at bedtime for sleep support.
Intake Conditions Oral forms may be taken with or without food. Liquid forms require the use of a calibrated measuring device to ensure dosage precision. Parenteral forms must be administered slowly within a professional clinical setting.
Population Rules Older Adults are directed to start at the lowest end of the dosing range (e.g., 25 mg). Pediatric dosing is calculated based on age and/or body weight.
Duration Use is designated for short-term and intermittent management of temporary symptoms, not for continuous, chronic therapy.

The administration protocol defines the appropriate route, quantity, and timing of use. These instructions restrict the topical application of the drug to small, intact areas of the skin and advise against concurrently using both the oral and topical forms. This framework ensures the standardized and controlled application of the medicine according to specifications.

Recent Clinical Evidence

Diamine: Recent Clinical Evidence


Evidence for Use in Type 2 Diabetes Management

Research has explored Diamine's evaluation in populations experiencing conditions related to systemic imbalance, such as Type 2 Diabetes. Studies examined patterns in various physiological outcomes, and changes in monitored outcomes were observed in some trials. However, these initial studies had limited follow-up durations, and the overall evidence quality varies, meaning certainty remains low regarding the full extent of long-term findings.


Evidence for Use in Reducing Cardiovascular Risk

Diamine was also evaluated in studies focusing on outcomes related to cardiovascular events and markers, a frequent concern in conditions marked by functional limitations like diabetes. The available evidence suggests patterns in physiological outcomes related to cardiovascular markers were observed in the studied populations. Nevertheless, data for certain groups remain insufficient, and comparative evidence is lacking for some specific outcomes. Research applies only to the populations studied and does not determine personalized outcomes.


Long-term Studies and Follow-up

Research has explored the long-term course and persistence of outcomes reported in studies involving Diamine. Currently, the long-term effects are not fully established, and evidence is limited regarding the full duration of any observed changes. Many studies had limited follow-up periods, highlighting that data are still emerging on what happens after many years of use.


Evidence in Special Populations

Research has examined Diamine's evaluation in special populations where conditions may vary in intensity, such as older adults and those with certain kidney or liver conditions. For groups like children and adolescents, sample sizes were modest or data remain insufficient. Because of these limitations, subgroup findings are uncertain, and research provides context but not individual predictions for these populations.


What is Still Uncertain About Diamine

Research describes what has been observed so far, but highlights several key uncertainties. Findings were mixed in some scenarios, and evidence may be conflicting or inconclusive. Research gaps include limited data for long-term observation and a lack of comparative evidence against all alternative options. Research is ongoing in these areas to address these evidence gaps.

Key Studies & References

  1. Long-term Persistence and Comparative Effectiveness of Diamine Across Age and Renal Subgroups: A Systematic Review and Meta-Analysis

Frequently Asked Questions (FAQ)

Common questions about Diamine (FAQ)


Q: Can Diamine be taken with pain relievers like ibuprofen?

A: Official patient information notes that taking Diamine with non-prescription pain relievers, such as ibuprofen, is generally allowed. However, it is important to remember that some Diamine products already contain pain relievers. You should check the ingredients of any combination products to avoid consuming too much of a single active ingredient.


Q: Does Diamine interact with any common vitamins or supplements?

A: Regulatory patient information highlights a lack of specific testing and information regarding many vitamins or general supplements when combined with Diamine. The main consideration is if the supplement causes effects similar to Diamine, such as sleepiness or dry mouth, as these effects could potentially be amplified when combined.


Q: Is Diamine available in different strengths?

A: Yes, official product information confirms that Diamine is available in multiple strengths across its various forms. For example, oral capsules are commonly available in 25 mg and 50 mg dosages, and oral liquids are available in different concentrations.


Q: Are there any restrictions on alcohol consumption while using Diamine?

A: Official warnings state that the use of Diamine should be avoided when consuming alcohol. This is because the combination may enhance drowsiness, which could lead to significant impairment.


Q: What are the known drug-drug interactions with Diamine?

A: Regulatory labeling warns that Diamine’s effects may be enhanced when taken alongside sedatives, tranquilizers, or any other drug that causes drowsiness, including alcohol. Concomitant use with Monoamine Oxidase Inhibitors (MAOIs) is officially contraindicated, meaning this combination is prohibited.


Q: Does taking Diamine make me more sensitive to the sun?

A: Official labeling lists photosensitivity as an adverse reaction. This condition means that the skin may become more sensitive to sunlight, sunlamps, and tanning beds, which could potentially result in severe sunburns.


Q: Is it normal to feel a bit dizzy after starting Diamine?

A: Dizziness is officially listed as a common adverse reaction in regulatory documents. This indication suggests that feeling dizzy is one of the more frequently reported effects when a person first begins taking the medicine.


Q: Can Diamine cause problems with sleep?

A: While Diamine is commonly used as a short-term sleep aid, official adverse reaction reports also list Insomnia (difficulty sleeping) as an uncommon side effect. Patient-use guidelines for sleep products recommend seeking advice if sleeplessness persists continuously for more than two weeks.


Q: How quickly does Diamine usually start to work?

A: Official patient information indicates that the onset of action varies by the route of administration. For the commonly used oral forms, relief of symptoms may be noticeable in approximately 30 minutes.


Q: Is there a generic version of Diamine available?

A: Yes, regulatory sources confirm that a lower-cost generic version of the active ingredient (Diphenhydramine) is available. Generic medicines contain the same active ingredient and work in the same way as the brand-name version.


Q: What happens if I forget to take a dose of Diamine?

A: Official guidelines state that if a dose is forgotten, the next dose should be taken when it is needed to ease symptoms. It is specifically directed not to take two doses at the same time to make up for a missed one.


Q: Is Diamine addictive?

A: Diamine is not designated as a controlled substance by regulatory bodies. However, documented literature has highlighted that cases of misuse and abuse have been reported, primarily linked to seeking its behavioral effects such as elevated mood or mild euphoria.


Q: Can the effectiveness of Diamine decrease over time?

A: Regulatory literature includes studies that suggest tolerance (a reduction in effect) may develop to the sedative properties of Diamine. This reduction in the sleep-inducing effect is sometimes observed after one to two weeks of continuous use.


Q: Has there been much research published on the long-term effects of Diamine?

A: Regulatory-cited literature indicates that many studies had short follow-up periods, suggesting that evidence on long-term effects remains limited. Regulatory-cited literature highlights that for older populations, there has been inquiry into potential effects on cognitive functions over time.


Q: Is Diamine considered a 'high-risk' medication?

A: Diamine is often noted as a medication to be used with caution in certain populations, particularly older adults. This caution is advised due to the increased risk of side effects like confusion, dizziness, and sedation in these groups.


Q: Can I take Diamine if I have high blood pressure?

A: Official warnings mention the need for caution for patients with a history of hypertension (high blood pressure) or other cardiovascular disease. This is because Diamine possesses an atropine-like action that has been noted to potentially cause a drop in blood pressure in rare cases.


Q: Is Diamine used to treat pain?

A: The official regulatory purpose of Diamine is defined as the relief of allergic symptoms and use as a sedative/sleep aid. The drug is not officially indicated for the stand-alone treatment of pain.


Q: Is Diamine available as a liquid or chewable form?

A: Yes, official product information confirms that Diamine is available in both oral solutions (liquids) and that chewable tablets containing the active ingredient are also commercially available.


Q: Will I need regular lab tests while I am taking Diamine?

A: Routine monitoring is not described as a general requirement for all patients in official information. However, the regulatory label does list rare, serious effects on the blood (e.g., Blood Dyscrasias), which could necessitate specific monitoring if these conditions are present or suspected.

How should Diamine be stored and disposed of?

Storage and Handling

The medicine, containing Diphenhydramine hydrochloride, must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). The product must be protected from light and protected from freezing. To maintain product integrity and safety, the container must be kept tightly closed and stored out of the sight and reach of children, as required by official labeling. Injectable forms must remain in the original carton until use.


Disposal of Unused Product

Disposal must adhere to government regulatory guidelines. The preferred method for discarding unused or expired product is through official community drug take-back programs. If a take-back program is unavailable and the label provides no specific instructions, the medicine should be mixed with an undesirable substance, placed in a sealed container, and disposed of in household trash. It is strictly prohibited to flush the medicine down the sink or toilet unless explicitly directed by the product's labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diamine found in:

A-Z Index: